An MD Anderson drug developed to starve cancer is tested on an...
For decades, combination chemotherapy has been the main treatment for patients with acute myeloid leukemia (AML) – an aggressive...
Grants nurture innovative approaches to pancreatic cancer...
New initiatives to improve the treatment of pancreatic cancer have earned two early-career investigators at MD Anderson multi-year...
Immunotherapy pioneer named one of TIME's most influential...
MD Anderson Chair of Immunology Jim Allison, Ph.D., whose pivotal work to attack cancer by treating the immune system instead of...
A new approach: Partnering with dentists...
The American Dental Association (ADA) and MD Anderson Cancer Center have announced a joint effort to improve patient outcomes through programs aimed at dental and medical professionals and the public to increase human papillomavirus (HPV) vaccinations and tobacco cessation for oral cancer prevention.
“ADA member dentists promise to put patients first, and as a profession we look for innovative ways to treat...
Andrew Sabin Family Fellows awarded $100,000 in research funding
Eight MD Anderson researchers have been named 2017 Andrew Sabin Family Fellows. The Andrew Sabin Family Fellowship Program provides...
MD Anderson genetics expert elected to National Academy of...
Guillermina Lozano, Ph.D., chair of Genetics at MD Anderson, is one of 84 new members and 21 foreign associates elected to the...
Dual procedures offer relief from lymphedema
Cancer patients who have undergone lymph node removal or radiation therapy as part of cancer treatment know all too well the pain and...
Breast cancer patients who respond to chemo may not need...
Select breast cancer patients who after undergoing chemotherapy as their first line of treatment show no residual cancer – a state...